Show Notes
We welcome Derek Kerton to AI Uncovered. Derek is the Founder and Chairman of the Autotech Council in Silicon Valley. His work brings global car companies together with startups to drive discussion around new technologies and their possible impact on the car industry. In this episode, Derek shares his expertise with Tim, offering valuable insights into the ever-evolving landscape of automotive tech. They discuss how cars are becoming safer and more efficient using innovation. They delve int...
More from AI Uncovered
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
We’re excited to welcome Oeystein Kjoersvik to AI Uncovered. Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying a quality-first approach to ensure safe, effective use of AI in GxP-regulated environments. In this episode, Tim and Oeystein delve into the challenges of adopting AI in regulated settings, the complexity of validating GenAI tools, and the transition from traditional processes to AI-augmented syst...
We’re thrilled to welcome Emmanuel Walckenaer, CEO of Yseop, back to AI Uncovered for a follow-up conversation on the rapid evolution of AI in biopharma. Since his last appearance, the industry has made significant strides in harnessing AI for regulatory submissions, clinical workflows, and medical writing—areas where Yseop is leading the charge in transforming content generation. In this episode, Tim and Emmanuel revisit the biggest AI breakthroughs of 2024 and explore how the pharmace...
We welcome Meredith Brown-Tuttle to AI Uncovered. Meredith is the Chief Regulatory Strategist at Regulatorium, where she applies her 33 years of experience in the pharmaceutical and biologics industry. She specializes in working with small and medium-sized drug, biologic and combination product companies to navigate global regulatory strategy, intelligence and submission requirements. With a strong focus on innovation, Meredith is dedicated to revolutionizing regulatory science by integ...
We welcome Michael Penlington to AI Uncovered. Michael has been working in Pharma for his entire career including roles in leading development of Vaccines and Clinical reporting at Novartis, as well as Senior Director roles of Science writing, Global Medical Writing and Medical Writing Center of Excellence at GSK. Most recently, Michael has taken on a new challenge as Director of Digital Clinical Development Solutions at Nurocor. In this episode, Tim and Michael discuss digital transformati...